ADMAEarningsglobenewswire

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

Sentiment:Positive (70)

Summary

2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 6, 2025 by globenewswire